SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 203.62-1.6%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (22248)6/15/1998 2:22:00 PM
From: Pseudo Biologist  Read Replies (1) of 32384
 
Henry, thanks for the comments. Here is a link (needs free registration) to the more recent article in "Skin and Allergy"

medscape.com

From the article:
"The Harvard Health Plan has 1,400 members who are HIV positive," he (dermatologist Richard A. Johnson of Harvard Medical School, Boston) said. "Fifty of those patients were on chemotherapy for Kaposi's sarcoma 1 year ago. Today, not a single HIV-positive patient is receiving chemotherapy for Kaposi's."

Of course, Panretin is not chemotherapy and one can conceive, given its mild side effect profile, that people would take it even in the above scenario. Has it been established that KS is likely due to a herpes-like virus, or is this still being debated?

Thanks,

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News